NEURoaid II (MLC901) in cognitively Impaired not demenTEd patientS (NEURITES): A pilot double blind, placebo-controlled randomized trial
10.1002/trc2.12161
Saved in:
Main Authors: | Chen, CLH, Nguyen, TH, Marasigan, S, Lee, CF, Lu, Q, Kandiah, N, de Silva, D, Chong, E, Venketasubramanian, N |
---|---|
Other Authors: | DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL) |
Format: | Article |
Published: |
Wiley
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/218817 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES) for the NEURITE investigators
by: Chen, C.L.H., et al.
Published: (2014) -
NeuroAid II (MLC901) in Haemorrhagic Stroke
by: Chai-Hoon Nowel Tan, et al.
Published: (2021) -
The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial
by: Chen, C.L.H., et al.
Published: (2021) -
The NeuroAiD II (MLC901) in Vascular Cognitive Impairment Study (NEURITES)
by: Chen, Christopher L.H., et al.
Published: (2017) -
Frequency and Clinical Impact of Serious Adverse Events on Post-Stroke Recovery with NeuroAiD (MLC601) versus Placebo: The CHInese Medicine Neuroaid Efficacy on Stroke Recovery Study
by: Venketasubramanian, Narayanaswamy, et al.
Published: (2021)